Escolar Documentos
Profissional Documentos
Cultura Documentos
Persistence Market Research Released New Market Report Global Market Study on
Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to
Account for Maximum Market Share by 2021.
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe
nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across
the globe. Easy application of nail paints is also expected to drive demand for dermatophytic
onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack
of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa,
and Latin America are expected to impede growth of the global dermatophytic
onychomycosis therapeutics market.
This report covers global and regional trends along with an analysis of the market potential.
North America is expected to account for over 43% revenue share of the total dermatophytic
onychomycosis therapeutics market by 2015 end i.e. holding the maximum market share.
Interested in report: Please follow the below links to meet your requirements;
Request for the Report Sample:
http://www.persistencemarketresearch.com/samples/5840
Market History:
Dermatophytic onychomycosis is a fungal infection of nail caused by dermatophytes. It
makes the nails look white and opaque, thickened, and brittle. People in the age group of 6065 years with diabetes or disease of the small blood vessels (peripheral vascular disease)
are at increased risk. Dermatophytic onychomycosis therapeutics market consists of drugs
used for a treatment of the disease.
The global dermatophytic onychomycosis therapeutics market was valued at US$ 2,870 Mn
in 2014. North America was the largest market for dermatophytic onychomycosis
therapeutics, accounting for over 43% revenue share of the overall market in 2014, followed
by Europe with around 28% share. North America market is expected to exhibit the highest
CAGR of 9.2% during the forecast period (20152021), followed by Europe. Factors such as
increasing per capita healthcare spending, rising aging population, consumers disposition
towards maintaining aesthetic appearing nails, and growing product innovation are expected
to support the growth of the dermatophytic onychomycosis therapeutics market during the
forecast period.
The global dermatophytic onychomycosis therapeutics market is projected to be valued at
US$ 3,057.8 Mn by the end of 2015 and is further expected to reach US$ 4,706.3 Mn by the
end of 2021, at a CAGR of 7.5%.
By product, the nail paint segment accounted for about 70% share of overall market value in
2014. By treatment, the oral segment was valued at US$ 861 Mn in 2014 and is expected to
increase at a CAGR of 5.2% during the forecast period to account for US$ 1,221.9 Mn by
2021. By distribution channels, the drug store segment contributed the highest revenue of
US$ 1,343.2 Mn, accounting for approximately 47% market share in 2014. Independent
pharmacies were the second-largest segment by distribution channel, accounting for about
20% revenue share in 2014.
Key players of the global dermatophytic onychomycosis therapeutics market include Valeant
Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma
AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc.
Table of Content
1. Assumptions and Acronyms Used
2. Research Methodology
3. Executive Summary
4. Dermatophytic Onychomycosis Therapeutics Market Overview
4.1. Introduction
4.1.1. Dermatophytic Onychomycosis Therapeutics Market Definition
4.1.2. Dermatophytic Onychomycosis Therapeutics Market Taxonomy
4.1.3. Dermatophytic Onychomycosis Therapeutics Market Parent Overview
4.2. Dermatophytic Onychomycosis Therapeutics Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.2.4. Trends
5. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Product
Type
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Product Type
5.1.2. Market Share & Basis Point (BPS) Analysis, By Product Type
5.2. Market Forecast, By Product Type
5.2.1. Tablet
5.2.1.1. Market Size Forecast and Y-o-Y Growth
5.2.1.2. Absolute $ Opportunity
5.2.1.3. Rx. Tablet
5.2.1.3.1. Market Size Forecast and Y-o-Y Growth
5.2.1.3.2. Absolute $ Opportunity
5.2.1.4. OTC Tablet
5.2.1.4.1. Market Size Forecast and Y-o-Y Growth
5.2.1.4.2. Absolute $ Opportunity
10
11
12
02:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
Opportunity, 20142021
Figure 03: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By
Product Type, 20142021
Figure 04: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis
By Product Type, 2014 & 2021
13
06:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
08:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
10:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
12:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
14:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
16:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
21:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
14
23:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
28:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
30:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
32:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
34:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
36:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
15
16
62:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
64:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
66:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
68:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
70:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
72:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
17
18
100:
Latin
America
Dermatophytic
Onychomycosis
Therapeutics
Market
Market
Growth
101:
MEA
Dermatophytic
Onychomycosis
Therapeutics
Y-o-Y
19
PMR stands committed to bringing more accuracy and speed to clients business decisions.
From ready-to-purchase market research reports to customized research solutions, PMRs
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
20